Related Experiment Video
Updated: Aug 25, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and
Ruth Cordoba-Rodriguez1, Hui Fang, Carla S R Lankford
1Division of Monoclonal Antibodies, Office of Biotechnology Products, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. frucht@cber.fda.gov
Abstract:
Anthrax lethal toxin (LT), a critical virulence factor for Bacillus anthracis, has been demonstrated to cleave and to inactivate mitogen-activated protein kinase kinases (MAPKKs) that propagate prosurvival signals in macrophages (1-5). Whether this action of anthrax LT leads to the production of proinflammatory cytokines by macrophages has been more controversial (6, 7). We now report that anthrax LT treatment leads to the specific extracellular release of interleukin (IL)-1beta and IL-18 by the murine macrophage cell lines, RAW264.7 and J774A.1. Studies of the processing of IL-1beta reveal that the levels of activated/cleaved IL-1beta in RAW264.7 and J774.A1 cells are increased following treatment with anthrax LT. Enhanced processing of IL-1beta directly correlates with increased levels in the activation of its upstream regulator, IL-1beta-converting enzyme/Caspase-1 (ICE). The extracellular release of IL-1beta and IL-18 in response to anthrax LT is ICE-dependent, as an ICE-specific inhibitor blocks this process. These data indicate that ICE, IL-1beta, and IL-18 are downstream effectors of anthrax LT in macrophages, providing the basis for new bioassays for anthrax LT activity and representing potential therapeutic targets.
Insights
Anthrax lethal toxin (LT) triggers the release of inflammatory cytokines IL-1beta and IL-18 from macrophages. This process is dependent on IL-1beta-converting enzyme (ICE), offering new targets for anthrax therapies.
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Anthrax lethal toxin (LT) is a key virulence factor of Bacillus anthracis.
- LT inactivates MAPKKs, crucial for macrophage survival signals.
- The effect of LT on proinflammatory cytokine production by macrophages remains debated.
Purpose of the Study:
- To investigate whether anthrax LT induces the release of proinflammatory cytokines from macrophages.
- To elucidate the mechanisms underlying LT-induced cytokine release.
Main Methods:
- Treatment of murine macrophage cell lines (RAW264.7 and J774A.1) with anthrax LT.
- Analysis of interleukin (IL)-1beta and IL-18 processing and release.
- Assessment of IL-1beta-converting enzyme (ICE) activation and inhibition.
Main Results:
- Anthrax LT treatment specifically induced extracellular release of IL-1beta and IL-18.
- LT enhanced the processing and activation of IL-1beta.
- Increased IL-1beta processing correlated with heightened ICE activation.
- The release of IL-1beta and IL-18 was dependent on ICE activity.
Conclusions:
- ICE, IL-1beta, and IL-18 are downstream effectors of anthrax LT in macrophages.
- These findings establish a mechanistic link between LT and specific cytokine release.
- The study provides a basis for developing novel bioassays for anthrax LT and potential therapeutic targets.
Related Concept Videos
Inhalation Anthrax
The Extrinsic Apoptotic Pathway
Caspases
Bacterial Toxins
The Intrinsic Apoptotic Pathway
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...

